Qatar Foundation’s Sidra Medicine is a leading regional research hospital and tertiary care facility for women and children, seeing nearly 200,000 patients in 2020. This session will explore the work at Sidra Medicine to take from bench to bedside the applications arising from newly analysed datasets of the Arab genome that will have benefits for patient care, pharmacogenomics and population health.
Session Chair Profile
Ph.D., CRO, Sidra Medicine
Biography
Dr Fakhro leads the Laboratory of Genomic Medicine, which focuses on bringing emerging genomic technologies from the lab close to the patients bedside. Over the past decade, his group has sequenced thousands of genomes from patients and volunteers across the Middle East, leading gene discovery efforts for a wide range of rare disorders, as well as landmark studies on population structure, genome structural variation, and the role of Islamic ethics in genome research. In addition to research and hospital duties, Dr Fakhro serves multiple leadership roles in Qatars growing biomedical ecosystem, including as Board Member of the Qatar Precision Medicine Institute, and Adjunct Faculty at both WeillCornell Medical College and Hamad Bin Khalifa University, where he teaches and supervises Masters and PhD students in genomics and precision medicine.
Speaker Profile
M.D., CMO, Sidra Medicine
Biography
Prof. Hijazi has nearly 40 years of experience in Congenital Cardiology and has pioneered several groundbreaking Interventional procedures in the field. He is an internationally recognized leader in the nonsurgical repair of congenital and structural heart defects in children and adults and in the development of novel transcatheter devices. As CMO of Sidra Medicine, Prof. Hijazi will be responsible for the overall management of the hospitals Medical operations, upholding its clinical excellence and patient safety programs and ensuring that patients in Qatar receive the highest standard of medical care.
Speaker Profile
M.D., President and CEO, The Jackson Labs
Biography
Edison T. Liu, M.D. is a global leader in translational genomic medicine who has been at the helm of research institutions in US academia, the US National Cancer Institute, and in Asia. He propelled Singapore’s genomics efforts onto the international stage, helping that country become a regional powerhouse in biomedical sciences. In the last ten years, Dr. Liu guided The Jackson Laboratory to a doubling of its size and revenues, and expanded its footprint from North America into China and Japan. As an active physician scientist, his research is centered on the complex genetics of human cancers with a special focus on the genomic biology of breast cancer. Dr. Liu has published over 320 papers, reviews, and books, and is a recipient of numerous national and international awards. He is an advisor to many institutions across the world seeking to establish a competitive position in the global biomedical sciences.
